JONATHAN R. GOODMAN - 01 Jun 2023 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role: Director
Signature: /s/ William L. Demers, by Power of Attorney for Jonathan R. Goodman
Issuer symbol: PNT
Transactions as of: 01 Jun 2023
Transactions value $: $0
Form type: 4
Filing time: 05 Jun 2023, 17:36:12 UTC
Previous filing: 21 Nov 2022
Next filing: 27 Dec 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PNT	Stock Option (Right to Buy)	Award	$0	+44,749		$0	44,749	01 Jun 2023	Common Stock	44,749	$9.12	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest 100% on the first anniversary of the grant date.